The GMRF Clinical Trials Unit is currently recruiting for the following clinical trials in Haematology:
PROTOCOL: CA058-1019 (PI: Doctor Nathan Klose)
Protocol Title: A Phase 3, Randomized, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of Alnuctamab Compared to Standard of Care Regimens in Participants with Relapsed or Refractory Multiple Myeloma (RRMM) – ALUMMINATE RRMM
Lay Title: A Study to Evaluate Efficacy and Safety of Alnuctamab Compared to Standard of Care Regimens in Participants With Relapsed or Refractory Mulitple Myeloma (RRMM)